{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T23:32:51Z","timestamp":1795044771740,"version":"4.10.2"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T00:00:00Z","timestamp":1693267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,29]],"date-time":"2023-08-29T00:00:00Z","timestamp":1693267200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R56AG074473"],"award-info":[{"award-number":["R56AG074473"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Parkinsons Dis."],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cognitive dysfunction is a salient feature of Parkinson\u2019s disease (PD) and Dementia with Lewy bodies (DLB). The onset of dementia reflects the spread of Lewy pathology throughout forebrain structures. The mere presence of Lewy pathology, however, provides limited indication of cognitive status. Thus, it remains unclear whether Lewy pathology is the de facto substrate driving cognitive dysfunction in PD and DLB. Through application of \u03b1-synuclein fibrils in vivo, we sought to examine the influence of pathologic inclusions on cognition. Following stereotactic injection of \u03b1-synuclein fibrils within the mouse forebrain, we measured the burden of \u03b1-synuclein pathology at 1-, 3-, and 6-months post-injection within subregions of the hippocampus and cortex. Under this paradigm, the hippocampal CA2\/3 subfield was especially susceptible to \u03b1-synuclein pathology. Strikingly, we observed a drastic reduction of pathology in the CA2\/3 subfield across time-points, consistent with the consolidation of \u03b1-synuclein pathology into dense somatic inclusions followed by neurodegeneration. Silver-positive degenerating neurites were observed prior to neuronal loss, suggesting that this might be an early feature of fibril-induced neurotoxicity and a precursor to neurodegeneration. Critically, mice injected with \u03b1-synuclein fibrils developed progressive deficits in spatial learning and memory. These findings support that the formation of \u03b1-synuclein inclusions in the mouse forebrain precipitate neurodegenerative changes that recapitulate features of Lewy-related cognitive dysfunction.<\/jats:p>","DOI":"10.1038\/s41531-023-00574-1","type":"journal-article","created":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T23:27:17Z","timestamp":1693265237000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Hippocampal subfield vulnerability to \u03b1-synuclein pathology precedes neurodegeneration and cognitive dysfunction"],"prefix":"10.1038","volume":"9","author":[{"given":"Dylan J.","family":"Dues","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An Phu Tran","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katelyn","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiyan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2359-5679","authenticated-orcid":false,"given":"Darren J.","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,8,29]]},"reference":[{"key":"574_CR1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrneurol.2012.242","volume":"9","author":"M Goedert","year":"2013","unstructured":"Goedert, M., Spillantini, M. G., Tredici, K. D. & Braak, H. 100 years of Lewy pathology. Nat. Rev. Neurol. 9, 13 (2013).","journal-title":"Nat. Rev. Neurol."},{"key":"574_CR2","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini, M. G. et al. \u03b1-Synuclein in Lewy bodies. Nature 388, 839\u2013840 (1997).","journal-title":"Nature"},{"key":"574_CR3","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/ana.20834","volume":"59","author":"JW Langston","year":"2006","unstructured":"Langston, J. W. The parkinson\u2019s complex: Parkinsonism is just the tip of the iceberg. Ann. Neurol. 59, 591\u2013596 (2006).","journal-title":"Ann. Neurol."},{"key":"574_CR4","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.tins.2010.04.003","volume":"33","author":"M Goedert","year":"2010","unstructured":"Goedert, M., Clavaguera, F. & Tolnay, M. The propagation of prion-like protein inclusions in neurodegenerative diseases. Trends Neurosci. 33, 317\u2013325 (2010).","journal-title":"Trends Neurosci."},{"key":"574_CR5","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak, H. et al. Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiol. Aging 24, 197\u2013211 (2003).","journal-title":"Neurobiol. Aging"},{"key":"574_CR6","doi-asserted-by":"crossref","first-page":"105687","DOI":"10.1016\/j.nbd.2022.105687","volume":"168","author":"MX Henderson","year":"2022","unstructured":"Henderson, M. X. et al. The roles of connectivity and neuronal phenotype in determining the pattern of \u03b1-synuclein pathology in Parkinson\u2019s disease. Neurobiol. Dis. 168, 105687 (2022).","journal-title":"Neurobiol. Dis."},{"key":"574_CR7","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1093\/brain\/awu193","volume":"137","author":"H Hall","year":"2014","unstructured":"Hall, H. et al. Hippocampal Lewy pathology and cholinergic dysfunction are associated with dementia in Parkinson\u2019s disease. Brain 137, 2493\u20132508 (2014).","journal-title":"Brain"},{"key":"574_CR8","volume":"7","author":"AKL Liu","year":"2019","unstructured":"Liu, A. K. L. et al. Hippocampal CA2 Lewy pathology is associated with cholinergic degeneration in Parkinson\u2019s disease with cognitive decline. Acta Neuropathol. Commun. 7, 61 (2019).","journal-title":"Acta Neuropathol. Commun."},{"key":"574_CR9","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1523\/JNEUROSCI.3047-16.2016","volume":"37","author":"DH Adamowicz","year":"2017","unstructured":"Adamowicz, D. H. et al. Hippocampal \u03b1-Synuclein in Dementia with Lewy bodies contributes to memory impairment and is consistent with spread of pathology. J. Neurosci. 37, 1675\u20131684 (2017).","journal-title":"J. Neurosci."},{"key":"574_CR10","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1212\/WNL.49.6.1570","volume":"49","author":"A Churchyard","year":"1997","unstructured":"Churchyard, A. & Lees, A. J. The relationship between dementia and direct involvement of the hippocampus and amygdala in Parkinson\u2019s disease. Neurology 49, 1570\u20131576 (1997).","journal-title":"Neurology"},{"key":"574_CR11","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s004010100390","volume":"102","author":"AJ Harding","year":"2001","unstructured":"Harding, A. J. & Halliday, G. M. Cortical Lewy body pathology in the diagnosis of dementia. Acta Neuropathol. 102, 355\u2013363 (2001).","journal-title":"Acta Neuropathol."},{"key":"574_CR12","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/mds.21956","volume":"23","author":"MA Hely","year":"2008","unstructured":"Hely, M. A., Reid, W. G. J., Adena, M. A., Halliday, G. M. & Morris, J. G. L. The Sydney multicenter study of Parkinson\u2019s disease: the inevitability of dementia at 20 years. Mov. Disord. 23, 837\u2013844 (2008).","journal-title":"Mov. Disord."},{"key":"574_CR13","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1093\/brain\/awh067","volume":"127","author":"T Foltynie","year":"2004","unstructured":"Foltynie, T., Brayne, C. E. G., Robbins, T. W. & Barker, R. A. The cognitive ability of an incident cohort of Parkinson\u2019s patients in the UK. The CamPaIGN study. Brain 127, 550\u2013560 (2004).","journal-title":"Brain"},{"key":"574_CR14","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/brain\/awm111","volume":"130","author":"CH Williams-Gray","year":"2007","unstructured":"Williams-Gray, C. H., Foltynie, T., Brayne, C. E. G., Robbins, T. W. & Barker, R. A. Evolution of cognitive dysfunction in an incident Parkinson\u2019s disease cohort. Brain 130, 1787\u20131798 (2007).","journal-title":"Brain"},{"key":"574_CR15","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/978-1-4939-9124-2_5","volume":"1948","author":"KO Papailiou","year":"2019","unstructured":"Papailiou, K. O. et al. Alpha-synuclein, methods and protocols. Methods Mol. Biol. Clifton N. J. 1948, 45\u201357 (2019).","journal-title":"Methods Mol. Biol. Clifton N. J."},{"key":"574_CR16","first-page":"59758","volume":"148","author":"JR Patterson","year":"2019","unstructured":"Patterson, J. R. et al. Generation of alpha-synuclein preformed fibrils from monomers and use in vivo. J. Vis. Exp. 148, 59758 (2019).","journal-title":"J. Vis. Exp."},{"key":"574_CR17","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1084\/jem.20112457","volume":"209","author":"KC Luk","year":"2012","unstructured":"Luk, K. C. et al. Intracerebral inoculation of pathological \u03b1-synuclein initiates a rapidly progressive neurodegenerative \u03b1-synucleinopathy in mice. J. Exp. Med. 209, 975\u2013986 (2012).","journal-title":"J. Exp. Med."},{"key":"574_CR18","doi-asserted-by":"crossref","first-page":"621","DOI":"10.3389\/fnins.2018.00621","volume":"12","author":"MF Duffy","year":"2018","unstructured":"Duffy, M. F. et al. Quality over quantity: advantages of using alpha-synuclein preformed fibril triggered synucleinopathy to model idiopathic Parkinson\u2019s disease. Front. Neurosci. 12, 621 (2018).","journal-title":"Front. Neurosci."},{"key":"574_CR19","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s00401-018-1829-8","volume":"135","author":"E Luna","year":"2018","unstructured":"Luna, E. et al. Differential \u03b1-synuclein expression contributes to selective vulnerability of hippocampal neuron subpopulations to fibril-induced toxicity. Acta Neuropathol. 135, 855\u2013875 (2018).","journal-title":"Acta Neuropathol."},{"key":"574_CR20","doi-asserted-by":"crossref","DOI":"10.1186\/s40478-019-0696-4","volume":"7","author":"X Wang","year":"2019","unstructured":"Wang, X. et al. Pathogenic alpha-synuclein aggregates preferentially bind to mitochondria and affect cellular respiration. Acta Neuropathol. Commun. 7, 41 (2019).","journal-title":"Acta Neuropathol. Commun."},{"key":"574_CR21","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1136\/jnnp.2003.031237","volume":"75","author":"A Br\u00fcck","year":"2004","unstructured":"Br\u00fcck, A., Kurki, T., Kaasinen, V., Vahlberg, T. & Rinne, J. O. Hippocampal and prefrontal atrophy in patients with early non-demented Parkinson\u2019s disease is related to cognitive impairment. J. Neurol. Neurosurg. Psychiatry 75, 1467 (2004).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"574_CR22","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.parkreldis.2014.08.024","volume":"20","author":"N Kandiah","year":"2014","unstructured":"Kandiah, N. et al. Hippocampal volume and white matter disease in the prediction of dementia in Parkinson\u2019s disease. Parkinsonism Relat. Disord. 20, 1203\u20131208 (2014).","journal-title":"Parkinsonism Relat. Disord."},{"key":"574_CR23","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1002\/mds.10444","volume":"18","author":"R Camicioli","year":"2003","unstructured":"Camicioli, R. et al. Parkinson\u2019s disease is associated with hippocampal atrophy. Mov. Disord. 18, 784\u2013790 (2003).","journal-title":"Mov. Disord."},{"key":"574_CR24","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ncb748","volume":"4","author":"H Fujiwara","year":"2002","unstructured":"Fujiwara, H. et al. \u03b1-Synuclein is phosphorylated in synucleinopathy lesions. Nat. Cell Biol. 4, 160\u2013164 (2002).","journal-title":"Nat. Cell Biol."},{"key":"574_CR25","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.nbd.2015.06.003","volume":"82","author":"KL Paumier","year":"2015","unstructured":"Paumier, K. L. et al. Intrastriatal injection of pre-formed mouse \u03b1-synuclein fibrils into rats triggers \u03b1-synuclein pathology and bilateral nigrostriatal degeneration. Neurobiol. Dis. 82, 185\u2013199 (2015).","journal-title":"Neurobiol. Dis."},{"key":"574_CR26","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1126\/science.1227157","volume":"338","author":"KC Luk","year":"2012","unstructured":"Luk, K. C. et al. Pathological \u03b1-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science 338, 949\u2013953 (2012).","journal-title":"Science"},{"key":"574_CR27","doi-asserted-by":"crossref","first-page":"104525","DOI":"10.1016\/j.nbd.2019.104525","volume":"130","author":"JR Patterson","year":"2019","unstructured":"Patterson, J. R. et al. Time course and magnitude of alpha-synuclein inclusion formation and nigrostriatal degeneration in the rat model of synucleinopathy triggered by intrastriatal \u03b1-synuclein preformed fibrils. Neurobiol. Dis. 130, 104525 (2019).","journal-title":"Neurobiol. Dis."},{"key":"574_CR28","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/hipo.10037","volume":"13","author":"T Groen","year":"2003","unstructured":"Groen, T., van, Miettinen, P. & Kadish, I. The entorhinal cortex of the mouse: organization of the projection to the hippocampal formation. Hippocampus 13, 133\u2013149 (2003).","journal-title":"Hippocampus"},{"key":"574_CR29","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neuron.2011.08.033","volume":"72","author":"LA Volpicelli-Daley","year":"2011","unstructured":"Volpicelli-Daley, L. A. et al. Exogenous \u03b1-synuclein fibrils induce Lewy Body pathology leading to synaptic dysfunction and neuron death. Neuron 72, 57\u201371 (2011).","journal-title":"Neuron"},{"key":"574_CR30","doi-asserted-by":"crossref","first-page":"3992","DOI":"10.3390\/ijms20163992","volume":"20","author":"S Kim","year":"2019","unstructured":"Kim, S. et al. Topographical visualization of the reciprocal projection between the medial septum and the hippocampus in the 5XFAD mouse model of Alzheimer\u2019s disease. Int. J. Mol. Sci. 20, 3992 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"574_CR31","doi-asserted-by":"crossref","first-page":"e64844","DOI":"10.1371\/journal.pone.0064844","volume":"8","author":"H Hall","year":"2013","unstructured":"Hall, H. et al. Characterization of cognitive deficits in rats overexpressing human alpha-synuclein in the ventral tegmental area and medial septum using recombinant adeno-associated viral vectors. PLoS ONE 8, e64844 (2013).","journal-title":"PLoS ONE"},{"key":"574_CR32","doi-asserted-by":"crossref","first-page":"eabg6677","DOI":"10.1126\/sciadv.abg6677","volume":"7","author":"EJ Cornblath","year":"2021","unstructured":"Cornblath, E. J. et al. Computational modeling of tau pathology spread reveals patterns of regional vulnerability and the impact of a genetic risk factor. Sci. Adv. 7, eabg6677 (2021).","journal-title":"Sci. Adv."},{"key":"574_CR33","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.expneurol.2017.10.017","volume":"299","author":"N Nouraei","year":"2018","unstructured":"Nouraei, N. et al. Critical appraisal of pathology transmission in the \u03b1-synuclein fibril model of Lewy body disorders. Exp. Neurol. 299, 172\u2013196 (2018).","journal-title":"Exp. Neurol."},{"key":"574_CR34","doi-asserted-by":"crossref","first-page":"ENEURO.0009-20.","DOI":"10.1523\/ENEURO.0009-20.2020","volume":"7","author":"DW Kasongo","year":"2020","unstructured":"Kasongo, D. W., Leo, G., de, Vicario, N., Leanza, G. & Legname, G. Chronic alpha-synuclein accumulation in rat hippocampus induces Lewy Bodies formation and specific cognitive impairments. Eneuro 7, ENEURO.0009-20.2020 (2020).","journal-title":"Eneuro"},{"key":"574_CR35","doi-asserted-by":"crossref","first-page":"716","DOI":"10.15252\/emmm.201607305","volume":"9","author":"S Blumenstock","year":"2017","unstructured":"Blumenstock, S. et al. Seeding and transgenic overexpression of alpha\u2010synuclein triggers dendritic spine pathology in the neocortex. EMBO Mol. Med. 9, 716\u2013731 (2017).","journal-title":"EMBO Mol. Med."},{"key":"574_CR36","doi-asserted-by":"crossref","DOI":"10.1186\/s40478-018-0537-x","volume":"6","author":"JM Froula","year":"2018","unstructured":"Froula, J. M. et al. \u03b1-Synuclein fibril-induced paradoxical structural and functional defects in hippocampal neurons. Acta Neuropathol. Commun. 6, 35 (2018).","journal-title":"Acta Neuropathol. Commun."},{"key":"574_CR37","doi-asserted-by":"crossref","first-page":"115","DOI":"10.5607\/en.2010.19.3.115","volume":"19","author":"KL O\u2019Malley","year":"2010","unstructured":"O\u2019Malley, K. L. The role of axonopathy in Parkinson\u2019s disease. Exp. Neurobiol. 19, 115\u2013119 (2010).","journal-title":"Exp. Neurobiol."},{"key":"574_CR38","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/s41591-018-0051-5","volume":"24","author":"SP Yun","year":"2018","unstructured":"Yun, S. P. et al. Block of A1 astrocyte conversion by microglia is neuroprotective in models of Parkinson\u2019s disease. Nat. Med. 24, 931\u2013938 (2018).","journal-title":"Nat. Med."},{"key":"574_CR39","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.nbd.2017.05.014","volume":"105","author":"H Abdelmotilib","year":"2017","unstructured":"Abdelmotilib, H. et al. \u03b1-Synuclein fibril-induced inclusion spread in rats and mice correlates with dopaminergic neurodegeneration. Neurobiol. Dis. 105, 84\u201398 (2017).","journal-title":"Neurobiol. Dis."},{"key":"574_CR40","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.neuron.2019.12.004","volume":"105","author":"MX Henderson","year":"2019","unstructured":"Henderson, M. X. et al. Glucocerebrosidase activity modulates neuronal susceptibility to pathological \u03b1-synuclein insult. Neuron 105, 822\u2013836.e7 (2019).","journal-title":"Neuron"},{"key":"574_CR41","volume":"7","author":"MX Henderson","year":"2019","unstructured":"Henderson, M. X. et al. LRRK2 inhibition does not impart protection from \u03b1-synuclein pathology and neuron death in non-transgenic mice. Acta Neuropathol. Commun. 7, 28 (2019).","journal-title":"Acta Neuropathol. Commun."},{"key":"574_CR42","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/s41593-019-0457-5","volume":"22","author":"MX Henderson","year":"2019","unstructured":"Henderson, M. X. et al. Spread of \u03b1-synuclein pathology through the brain connectome is modulated by selective vulnerability and predicted by network analysis. Nat. Neurosci. 22, 1248\u20131257 (2019).","journal-title":"Nat. Neurosci."},{"key":"574_CR43","doi-asserted-by":"crossref","first-page":"e2204835119","DOI":"10.1073\/pnas.2204835119","volume":"119","author":"T-I Kam","year":"2022","unstructured":"Kam, T.-I. et al. Amelioration of pathologic \u03b1-synuclein-induced Parkinson\u2019s disease by irisin. Proc. Natl Acad. Sci. 119, e2204835119 (2022).","journal-title":"Proc. Natl Acad. Sci."},{"key":"574_CR44","doi-asserted-by":"crossref","first-page":"16533","DOI":"10.1038\/s41598-017-15813-8","volume":"7","author":"M Karampetsou","year":"2017","unstructured":"Karampetsou, M. et al. Phosphorylated exogenous alpha-synuclein fibrils exacerbate pathology and induce neuronal dysfunction in mice. Sci. Rep. 7, 16533 (2017).","journal-title":"Sci. Rep."},{"key":"574_CR45","doi-asserted-by":"crossref","first-page":"e70274","DOI":"10.1371\/journal.pone.0070274","volume":"8","author":"KL Paumier","year":"2013","unstructured":"Paumier, K. L. et al. Behavioral characterization of A53T mice reveals early and late stage deficits related to Parkinson\u2019s disease. PLoS ONE 8, e70274 (2013).","journal-title":"PLoS ONE"},{"key":"574_CR46","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/978-1-4939-8994-2_7","volume":"1916","author":"A-K Kraeuter","year":"2018","unstructured":"Kraeuter, A.-K., Guest, P. C. & Sarnyai, Z. Pre-clinical models, techniques and protocols. Methods Mol. Biol. 1916, 87\u201391 (2018).","journal-title":"Methods Mol. Biol."},{"key":"574_CR47","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/0092-8674(95)90010-1","volume":"81","author":"ME Bach","year":"1995","unstructured":"Bach, M. E., Hawkins, R. D., Osman, M., Kandel, E. R. & Mayford, M. Impairment of spatial but not contextual memory in CaMKII mutant mice with a selective loss of hippocampal ltp in the range of the \u03b8 frequency. Cell 81, 905\u2013915 (1995).","journal-title":"Cell"},{"key":"574_CR48","doi-asserted-by":"crossref","first-page":"e2744","DOI":"10.21769\/BioProtoc.2744","volume":"8","author":"M Pitts","year":"2018","unstructured":"Pitts, M. Barnes maze procedure for spatial learning and memory in mice. Bio Protoc. 8, e2744 (2018).","journal-title":"Bio Protoc."},{"key":"574_CR49","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1037\/h0077579","volume":"93","author":"CA Barnes","year":"1979","unstructured":"Barnes, C. A. Memory deficits associated with senescence: a neurophysiological and behavioral study in the rat. J. Comp. Physiol. Psychol. 93, 74\u2013104 (1979).","journal-title":"J. Comp. Physiol. Psychol."},{"key":"574_CR50","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/nan.12698","volume":"47","author":"DG Coughlin","year":"2021","unstructured":"Coughlin, D. G., Grossman, M., Trojanowski, J. Q. & Irwin, D. J. Hippocampal subfield pathologic burden in Lewy body diseases versus Alzheimer\u2019s disease. Neuropathol. Appl. Neurobiol. 47, 707\u2013708 (2021).","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"574_CR51","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/BF00296742","volume":"87","author":"DW Dickson","year":"1994","unstructured":"Dickson, D. W. et al. Immunoreactivity profile of hippocampal CA2\/3 neurites in diffuse Lewy body disease. Acta Neuropathol. 87, 269\u2013276 (1994).","journal-title":"Acta Neuropathol."},{"key":"574_CR52","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1212\/WNL.41.9.1402","volume":"41","author":"DW Dickson","year":"1991","unstructured":"Dickson, D. W. et al. Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer\u2019s disease: light and electron microscopic immunocytochemistry of CA2-3 neurites specific to DLBD. Neurology 41, 1402\u20131402 (1991).","journal-title":"Neurology"},{"key":"574_CR53","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s00401-005-0004-1","volume":"111","author":"H Fujishiro","year":"2006","unstructured":"Fujishiro, H. et al. Depletion of cholinergic neurons in the nucleus of the medial septum and the vertical limb of the diagonal band in dementia with Lewy bodies. Acta Neuropathol. 111, 109\u2013114 (2006).","journal-title":"Acta Neuropathol."},{"key":"574_CR54","doi-asserted-by":"crossref","first-page":"104708","DOI":"10.1016\/j.nbd.2019.104708","volume":"134","author":"LE Stoyka","year":"2019","unstructured":"Stoyka, L. E. et al. Behavioral defects associated with amygdala and cortical dysfunction in mice with seeded \u03b1-synuclein inclusions. Neurobiol. Dis. 134, 104708 (2019).","journal-title":"Neurobiol. Dis."},{"key":"574_CR55","doi-asserted-by":"crossref","first-page":"136273","DOI":"10.1016\/j.neulet.2021.136273","volume":"765","author":"Q Zhang","year":"2021","unstructured":"Zhang, Q. et al. Cortical alpha-synuclein preformed fibrils do not affect interval timing in mice. Neurosci. Lett. 765, 136273 (2021).","journal-title":"Neurosci. Lett."},{"key":"574_CR56","doi-asserted-by":"crossref","first-page":"fcab273","DOI":"10.1093\/braincomms\/fcab273","volume":"3","author":"S Blumenstock","year":"2021","unstructured":"Blumenstock, S. et al. Cortical circuit dysfunction in a mouse model of alpha-synucleinopathy in vivo. Brain Commun. 3, fcab273 (2021).","journal-title":"Brain Commun."},{"key":"574_CR57","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.expneurol.2016.05.040","volume":"283","author":"Q Hu","year":"2016","unstructured":"Hu, Q. et al. Aberrant adenosine A2A receptor signaling contributes to neurodegeneration and cognitive impairments in a mouse model of synucleinopathy. Exp. Neurol. 283, 213\u2013223 (2016).","journal-title":"Exp. Neurol."},{"key":"574_CR58","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3233\/JPD-2011-11043","volume":"1","author":"I Magen","year":"2011","unstructured":"Magen, I. & Chesselet, M.-F. Mouse models of cognitive deficits due to alpha-synuclein pathology. J. Parkinsons Dis. 1, 217\u2013227 (2011).","journal-title":"J. Parkinsons Dis."},{"key":"574_CR59","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1084\/jem.20160368","volume":"213","author":"NL Rey","year":"2016","unstructured":"Rey, N. L. et al. Widespread transneuronal propagation of \u03b1-synucleinopathy triggered in olfactory bulb mimics prodromal Parkinson\u2019s disease. J. Exp. Med. 213, 1759\u20131778 (2016).","journal-title":"J. Exp. Med."},{"key":"574_CR60","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.3233\/JPD-212847","volume":"11","author":"NK Polinski","year":"2021","unstructured":"Polinski, N. K. A summary of phenotypes observed in the in vivo rodent alpha-synuclein preformed fibril model. J. Parkinsons Dis. 11, 1555\u20131567 (2021).","journal-title":"J. Parkinsons Dis."},{"key":"574_CR61","doi-asserted-by":"crossref","first-page":"8728","DOI":"10.1007\/s12035-018-1007-y","volume":"55","author":"K Becker","year":"2018","unstructured":"Becker, K. et al. Detecting alpha synuclein seeding activity in formaldehyde-fixed MSA patient tissue by PMCA. Mol. Neurobiol. 55, 8728\u20138737 (2018).","journal-title":"Mol. Neurobiol."},{"key":"574_CR62","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1038\/nprot.2014.143","volume":"9","author":"LA Volpicelli-Daley","year":"2014","unstructured":"Volpicelli-Daley, L. A., Luk, K. C. & Lee, V. M.-Y. Addition of exogenous \u03b1-synuclein preformed fibrils to primary neuronal cultures to seed recruitment of endogenous \u03b1-synuclein to Lewy body and Lewy neurite\u2013like aggregates. Nat. Protoc. 9, 2135\u20132146 (2014).","journal-title":"Nat. Protoc."},{"key":"574_CR63","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.nbd.2014.08.027","volume":"71","author":"E Tsika","year":"2014","unstructured":"Tsika, E. et al. Conditional expression of Parkinson\u2019s disease-related R1441C LRRK2 in midbrain dopaminergic neurons of mice causes nuclear abnormalities without neurodegeneration. Neurobiol. Dis. 71, 345\u2013358 (2014).","journal-title":"Neurobiol. Dis."},{"key":"574_CR64","first-page":"50978","volume":"82","author":"M Angoa-P\u00e9rez","year":"2013","unstructured":"Angoa-P\u00e9rez, M., Kane, M. J., Briggs, D. I., Francescutti, D. M. & Kuhn, D. M. Marble burying and nestlet shredding as tests of repetitive, compulsive-like behaviors in mice. J. Vis. Exp 82, 50978 (2013).","journal-title":"J. Vis. Exp"},{"key":"574_CR65","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/nprot.2007.44","volume":"2","author":"AA Walf","year":"2007","unstructured":"Walf, A. A. & Frye, C. A. The use of the elevated plus maze as an assay of anxiety-related behavior in rodents. Nat. Protoc. 2, 322\u2013328 (2007).","journal-title":"Nat. Protoc."},{"key":"574_CR66","doi-asserted-by":"crossref","unstructured":"Sargent, D. et al. Neuronal VPS35 deletion induces spinal cord motor neuron degeneration and early post-natal lethality. Brain Commun. 3, fcab208 (2021).","DOI":"10.1093\/braincomms\/fcab208"},{"key":"574_CR67","doi-asserted-by":"crossref","first-page":"D996","DOI":"10.1093\/nar\/gks1042","volume":"41","author":"SM Sunkin","year":"2013","unstructured":"Sunkin, S. M. et al. Allen Brain Atlas: an integrated spatio-temporal portal for exploring the central nervous system. Nucleic Acids Res. 41, D996\u2013D1008 (2013).","journal-title":"Nucleic Acids Res."}],"container-title":["npj Parkinson's Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41531-023-00574-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-023-00574-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41531-023-00574-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T07:07:59Z","timestamp":1700377679000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41531-023-00574-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,29]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["574"],"URL":"https:\/\/doi.org\/10.1038\/s41531-023-00574-1","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2023.04.12.536572","asserted-by":"object"}]},"ISSN":["2373-8057"],"issn-type":[{"value":"2373-8057","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,29]]},"assertion":[{"value":"15 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"125"}}